Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Celladon Corporation Announces Publication Of Data From Its Stem Cell Factor Gene Therapy Program In Circulation Heart Failure

October 27, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 27, 2014 (GLOBE NEWSWIRE) — Celladon Corporation (Nasdaq:CLDN), a biotechnology industry leader in the field of cardiovascular gene therapy, today announced together with researchers at the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai, the results of pre…

International Myeloma Foundation???s Research Division Issues New Guidelines For Early Diagnosis Of Multiple Myeloma

October 27, 2014 – 5:00 am | Edit Post

NORTH HOLLYWOOD, Calif.–(BUSINESS WIRE)–The International Myeloma Foundation (IMF) improving the quality of life of myeloma patients while working toward prevention and a cure today announced that the organizations research division, the International Myeloma Working Group (IMWG), has issued new criteria for diagnosing multiple myeloma. Myeloma is a cancer of cells in the bone marrow that affects…

Cytori Therapeutics, Inc. To Webcast Third Quarter Financial Results On November 6

October 27, 2014 – 5:00 am | Edit Post

Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its third quarter financial results and business update on Thursday, November 6, 2014 at 5:30 PM Eastern Time. The dial-in information is as follows: Dial-In Number: 1.877.402.3914Conference ID: 26821138 Help employers find you! Check out all the

Arena Pharmaceuticals, Inc. Announces Third Quarter 2014 Conference Call And Webcast On Monday, November 3

October 27, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 27, 2014 /PRNewswire/ — Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announcedthat it will host a conference call and webcast at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time) on Monday, November 3, 2014…

DJO Global Announces Date For Release Of Third Quarter 2014 Results

October 27, 2014 – 5:00 am | Edit Post

DJO Global, Inc., a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced the following information for the release of its third quarter 2014 financial results and a conference call to discuss those results. Help employers find you! Check out all the

Tandem Diabetes Care Announces Schedule Change For Third Quarter 2014 Earnings Press Release And Conference Call

October 27, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 24, 2014 (GLOBE NEWSWIRE) — Tandem Diabetes Care, Inc. (Nasdaq:TNDM), a medical device company and manufacturer of the t:slim Insulin Pump, today announced a schedule change for its third quarter 2014 results. The company will now release its third quarter …

ChinaBio?? Partnering Forum 2015 To Be Held In Shanghai, China April 22???23, 2015

October 27, 2014 – 5:00 am | Edit Post

The 2015 edition of ChinaBio Partnering Forum, Chinas premier life science partnering event, will be held April 2223 in Shanghai. Shanghai is the largest city proper in the world and home to over 1,000 life science companies. In 2014, the Forum was attended by 848 delegates from 425 companies and 25 countries, making it the largest partnering conference in China. Pharma and biotech companies…

Ligand Pharmaceuticals Inc. Reports Third Quarter 2014 Financial Results

October 27, 2014 – 5:00 am | Edit Post

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today reported financial results for the three and nine months ended September 30, 2014, and provided an operating forecast and program updates. Financial highlights for the third quarter of 2014 include (all comparisons are with the third quarter of 2013): Help employers find you! Check out all the

Ciclofilin Pharmaceuticals Appoints <b>Stephen F. Keane</b> As Senior VP Of Corporate Development

October 27, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 27, 2014 (GLOBE NEWSWIRE) — Ciclofilin Pharmaceuticals Inc. (“Ciclofilin” or the “Company”), a developer of broad spectrum antiviral medications, announced today the appointment of Stephen F. Keane as Senior Vice President of Corporate Development. In this role, Mr. Keane will be responsible…

OncoSec Medical Inc. Receives Phase 1 SBIR Funding For Development Of Novel Electroporation Technologies

October 27, 2014 – 5:00 am | Edit Post

SAN DIEGO–(BUSINESS WIRE)–OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, received a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Health (NIH). The grant will fund collaborative research between OncoSec and Old Dominion University (ODU) to evaluate and develop novel electroporation technologies. …